期刊文献+

氨溴索辅助高频振荡通气治疗重症新生儿胎粪吸入综合征 被引量:3

Ambroxol with High Frequency Oscillation on Neonatal Meconium Aspiration Syndrome
下载PDF
导出
摘要 目的:观察氨溴索辅助高频振荡通气治疗重症新生儿胎粪吸入综合征(MAS)的疗效。方法:选择符合新生儿胎粪吸入综合征诊断标准需机械通气治疗的足月新生儿16例,开始高频通气同时予氨溴索15 mg/kg静脉推注,6 h 1次,连用5天。观察治疗开始0 h、2 h、8 h、24 h、48 h FiO2、PaO2、a/APO2、PaCO2及Paw的动态变化。结果:应用氨溴索辅助高频通气后2 h,FiO2由(0.85±0.10)下降至(0.69±0.12)(P<0.05),a/APO2、PaO2由(0.10±0.03,38.9±4.3mmHg)上升至(0.21±0.06,48.1±3.6 mmHg)(P<0.05),以后FiO2继续下降,PaO2、a/A逐步上升;PaCO2在2 h内也有下降,由治疗前的(68.1±6.9 mmHg)到(60.2±5.5 mmHg)(P<0.05),8 h下降更加明显(P<0.01),Paw在8 h也开始由(15.3±1.8 cm H2O)降低至(13.2±2.5 cm H2O),与治疗前比较差异有显著性意义(P<0.05)。结论:氨溴索能提高MAS患儿通气及换气功能,降低呼吸机参数,减少肺损伤的发生。 Objective: Evaluation the effect of Ambroxol on neonatal meconium aspiration syndrome (MAS) under high frequency oscillation. Methods: 16 MAS patients were treated by Ambroxol with high frequency oscillation. Ambroxol (15 mg/kg) was given every six hours in five continuous days. FiO2、Paw、a/APO2、PaO2、PaCO2、incidence of complications and mortality were investigated at 2 h,8 h,24 h,48 h after first dose of Ambroxol. Results: Blood gas exchanges and hemodynamics were evaluated before and after treatment. In the first 2 h of treatment FiO2 rapidly decreased from(0.85±0.10) to (0.69±0.12)(P<0.05) ,a/APO2 and PaO2 increased from (0.10±0.03,38.9±4.3 mmHg) to (0.21±0.06,48.1±3.6 mmHg)(P<0.05), PaCO2 decreased from (68.1±6.9 mmHg) to (60.2±5.5 mmHg)(P<0.05),and reduced significandy at 8 h to (50.5±5.9 mmHg) (P<0.01). Paw decreased at 8 h from(15.3±1.8 cm H2O) to (13.2±2.5 cm H2O)(P<0.05). Conclusion: Ambroxol can improve pulmonary exchang function of the patients with MAS,reduce MAP,FiO2 of the patients with ventilation and incidences of air leak and lung injury.
出处 《岭南急诊医学杂志》 2004年第2期97-98,105,共3页 Lingnan Journal of Emergency Medicine
关键词 氨溴索 高频振荡通气 联合治疗 新生儿 重症胎粪吸入综合征 呼吸衰竭 high frequency oscillation Ambroxol neonatal meconium aspiration syndrome
  • 相关文献

参考文献2

二级参考文献9

  • 1Suresh GK, Soll RF. Current surfactant use in premature infants [J]. Clin Perinatol, 2001, 8: 671-94.
  • 2Wiswell TE. Expanded uses of surfactant therapy [J]. Clin Perinatol, 2001,8 : 695-711.
  • 3Suresh GK, Soll RF. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents [J]. Paediatr Drugs, 2002, 4:485-92.
  • 4Suresh GK, Soll RF. Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents? Paediatr Drugs, 2002, 4:485-492.
  • 5Dargaville PA, South M, McDougall PN. Surfactant and surfactant inhibitors in meconium aspiration syndrome. J pediatr,2001, 138:113-115.
  • 6Herting E, Gefeller O, Land M, et al. Surfactant treatment of neonates with respiratory failure and gruop B streptococcal infection. Pediatrics, 2000,106: 957-964.
  • 7曾健生.高频振荡通气的肺复张策略[J].国外医学(呼吸系统分册),1998,18(3):157-159. 被引量:6
  • 8李杰,樊寻梅,宋国维,李克华,郭在晨,叶鸿瑁,崔玉涛,甘小庄,王颍,朴梅花.肺表面活性制剂治疗新生儿呼吸窘迫综合征多中心临床观察[J].中华儿科杂志,2000,38(6):344-347. 被引量:118
  • 9宋国维.肺表面活性物质的代谢及临床应用[J].实用儿科临床杂志,2003,18(2):84-87. 被引量:72

共引文献47

同被引文献32

引证文献3

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部